Document Type and Number:
Japanese Patent JPWO2022191293
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide: a method for measuring the percentage of CD16-positive monocytes and the total monocytes in all nucleated cells in a sample; and a method for measuring the percentage of CD-16 positive monocytes among the total monocytes. The methods of the present invention are: a method for measuring the percentage of CD16-positive monocytes in all nucleated cells in a human sample, the method including analyzing a non-methylated state of one or more CpG positions in a marker region comprising at least one DNA sequence selected from the group consisting of SEQ ID NOS: 22, 25, 28, 31 and 34, wherein the percentage of CD16-positive monocytes in all nucleated cells in a human sample are calculated by using the percentage of non-methylated states of one or more CpG positions obtained via said analysis; and a method for measuring the percentage of CD16-positive monocytes in the total monocytes by using the aforementioned method.
Application Number:
JP2023505640A
Publication Date:
September 15, 2022
Filing Date:
March 10, 2022
Export Citation:
Previous Patent: JPWO2022191292
Next Patent: Novel modified acid compositions as replacements for conventional acids in the oil and gas industry
Next Patent: Novel modified acid compositions as replacements for conventional acids in the oil and gas industry